GR3024115T3 - Process for manufacturing von Willebrand factor having a very high purity - Google Patents

Process for manufacturing von Willebrand factor having a very high purity

Info

Publication number
GR3024115T3
GR3024115T3 GR970401765T GR970401765T GR3024115T3 GR 3024115 T3 GR3024115 T3 GR 3024115T3 GR 970401765 T GR970401765 T GR 970401765T GR 970401765 T GR970401765 T GR 970401765T GR 3024115 T3 GR3024115 T3 GR 3024115T3
Authority
GR
Greece
Prior art keywords
von willebrand
willebrand factor
factor
high purity
manufacturing
Prior art date
Application number
GR970401765T
Other languages
English (en)
Inventor
Bernard Dazey
Mohamed Hamsany
Gerard Vezon
Original Assignee
Aquitaine Dev Transf Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9399373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3024115(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquitaine Dev Transf Sanguine filed Critical Aquitaine Dev Transf Sanguine
Publication of GR3024115T3 publication Critical patent/GR3024115T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR970401765T 1990-08-02 1997-07-16 Process for manufacturing von Willebrand factor having a very high purity GR3024115T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009917A FR2665449B1 (fr) 1990-08-02 1990-08-02 Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.

Publications (1)

Publication Number Publication Date
GR3024115T3 true GR3024115T3 (en) 1997-10-31

Family

ID=9399373

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401765T GR3024115T3 (en) 1990-08-02 1997-07-16 Process for manufacturing von Willebrand factor having a very high purity

Country Status (9)

Country Link
US (1) US5252710A (el)
EP (1) EP0469985B1 (el)
JP (1) JP2559645B2 (el)
AT (1) ATE152128T1 (el)
DE (2) DE69125764T2 (el)
DK (1) DK0469985T3 (el)
ES (1) ES2038095T3 (el)
FR (1) FR2665449B1 (el)
GR (1) GR3024115T3 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760183A (en) * 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
KR970060724A (ko) * 1996-01-16 1997-08-12 김광호 백업용 배터리 동작의 표시방법 및 그 감지회로
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
EP1820516B1 (en) * 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
JP4663837B2 (ja) * 1999-12-24 2011-04-06 一般財団法人化学及血清療法研究所 第▲ｖｉｉｉ▼因子を主成分とする血小板減少に伴う出血疾患の予防・治療用医薬組成物
DE60042171D1 (de) * 1999-12-24 2009-06-18 Chemo Sero Therapeut Res Inst Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
PL1656410T3 (pl) * 2003-07-22 2010-08-31 Nektar Therapeutics Sposób wytwarzania sfunkcjonalizowanych polimerów z polimerycznych alkoholi
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
WO2007011802A1 (en) 2005-07-18 2007-01-25 Nektar Therapeutics Al, Corporation Method for preparing branched functionalized polymers using branched polyol cores
KR20110017420A (ko) * 2008-06-04 2011-02-21 바이엘 헬스케어 엘엘씨 폰 빌레브란트 질환의 치료를 위한 ｆｖｉｉｉ 뮤테인
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
IT1396528B1 (it) 2009-01-19 2012-12-14 Kedrion Spa Nuovo processo di purificazione altamente selettivo di due proteine plasmatiche: von willebrand factor (vwf) e fibronectina (fn).

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
FR2570276B1 (fr) * 1984-09-18 1987-09-04 Immunotech Sa Procede d'obtention du complexe fviii/vwf a usage therapeutique et produits en resultant
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
FR2650393A1 (fr) * 1989-07-28 1991-02-01 Herault Ctre Rgl Transfusion S Methode de purification du facteur vii (f viii) par chromatographie echangeuse d'ions

Also Published As

Publication number Publication date
DE69125764T2 (de) 1997-11-13
JPH04234400A (ja) 1992-08-24
US5252710A (en) 1993-10-12
EP0469985B1 (en) 1997-04-23
ES2038095T1 (es) 1993-07-16
DK0469985T3 (da) 1997-10-20
EP0469985A1 (en) 1992-02-05
ATE152128T1 (de) 1997-05-15
ES2038095T3 (es) 1997-09-16
DE469985T1 (de) 1992-10-15
JP2559645B2 (ja) 1996-12-04
FR2665449B1 (fr) 1995-04-14
DE69125764D1 (de) 1997-05-28
FR2665449A1 (fr) 1992-02-07

Similar Documents

Publication Publication Date Title
GR3024115T3 (en) Process for manufacturing von Willebrand factor having a very high purity
UA11061A (uk) Спосіб розділеhhя білків крові
IT1255983B (it) Procedimento per la purificazione di un amminoacido usando una resina scambiatrice di ioni
ZA853887B (en) Nitrogen adsorption process
FR2651437B1 (el)
CA2123699A1 (en) An Adsorbent for Cellular Fibronectin, a Method for Fractional Purification of Fibronectin and a Method of Hemocatharisis
EP0242544A3 (en) Adsorbent for chromatography, method of producing the same, and column system for chromatography
MY101885A (en) A process for separating and purifying metallic elements by displacement chromatography
ES2058538T3 (es) Compuestos de proteina a purificados y procedimiento para su preparacion.
DE3471106D1 (en) A process for the recovery of a peptide-containing compound
ES2105033T3 (es) Metodo de purificacion de proteinas.
HU9301038D0 (en) Method for producing virus-safe vii factor of high purity
CA2136235A1 (en) Method for purification of acetonitrile
ES2042027T3 (es) Procedimiento de recuperacion de acido citrico a partir de un licor que lo contiene.
MX9709893A (es) Fragmentos terapeuticos del factor von willebrand.
AU574133B2 (en) Concentration and purification of hydrogen gas by adsorption process
GR930300095T1 (en) Process for preparing highly purified fibrinogen
JPS6487685A (en) Production of liquid crystal composition of high resistivity
HUT55335A (en) Process for adsorptive separating para-xilol with tetraline desorbent
ES2055875T3 (es) Procedimiento de fabricacion del factor antihemofilico (fviiic) con una pureza muy elevada.
EP0167152A3 (en) Protease adsorbent and process for purifying tpa utilizing the same
DK1015568T3 (da) Fremgangsmåde til produktion af rDSPAalfa1
EP0711786A3 (el)
NO832331L (no) Fremgangsmaate for rensing av soetningsmiddelopploesninger
KR940013535A (ko) 순수한 인 혈액 응고 제2인자 및 제9인자의 정제 방법